
Opinion|Videos|September 20, 2024
Current Advancements in Biomarker Research
The panel explores promising biomarker research that has the potential to significantly impact patient care in prostate cancer.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- What current advancements in biomarker research are you most excited about? (Brian Richardson, MD)
- Lysine-specific demethylase-1
- Appl1, Sortilin, and Syndecan-1
- Please highlight any others.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
2
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
3
Kari Tikkinen, MD, PhD, discusses POISE-3 findings on tranexamic acid in urologic surgery
4
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
5















